-
Product Insights
Premature Ejaculation – Drugs In Development, 2023
Global Markets Direct’s, ‘Premature Ejaculation - Drugs In Development, 2023’, provides an overview of the Premature Ejaculation pipeline landscape. The report provides comprehensive information on the therapeutics under development for Premature Ejaculation, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Erectile Dysfunction – Drugs In Development, 2023
Global Markets Direct’s, ‘Erectile Dysfunction - Drugs In Development, 2023’, provides an overview of the Erectile Dysfunction pipeline landscape. The report provides comprehensive information on the therapeutics under development for Erectile Dysfunction, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Erectile Dysfunction Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Erectile dysfunction, or ED, is the inability of a man to have an erection hard enough to have sexual intercourse. It can also be known as impotence. The predisposing factors include tobacco usage, overweight, injuries, drug and alcohol use, and medications, including antidepressants, antihistamines, and medications to treat high blood pressure, pain, or prostate cancer. The Erectile Dysfunction drugs in development market research report provide comprehensive information on the therapeutics under development for Erectile Dysfunction, complete with analysis by stage...